SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
NCT05022420 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-04-05
Summary
Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
Conditions
- Tolerance
- Biopsy Site Itching
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-19
- Primary Completion
- 2025-02-18
- Completion
- 2025-02-18
Countries
- France
Study Locations
More Related Trials
-
Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome
NCT05312944 ·Status: UNKNOWN
-
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415 ·Status: RECRUITING
-
Catalytic Antibodies and Lupus in Martinique
NCT01157468 ·Status: COMPLETED
-
Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT03254823 ·Status: COMPLETED
-
Abnormalities of B Lymphocytes During Systemic Lupus
NCT00401141 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies
NCT06412614 ·Status: NOT_YET_RECRUITING
-
Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
NCT06680310 ·Status: NOT_YET_RECRUITING
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
NCT04220034 ·Status: COMPLETED
-
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
NCT02922114 ·Status: COMPLETED ·Phase: NA
-
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
NCT04320680 ·Status: RECRUITING ·Phase: NA
-
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560 ·Status: COMPLETED
-
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
NCT05394922 ·Status: RECRUITING
-
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
NCT06551389 ·Status: RECRUITING
-
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
NCT02891213 ·Status: UNKNOWN
-
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
NCT06675422 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
NCT06593041 ·Status: RECRUITING
-
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
NCT06435468 ·Status: RECRUITING ·Phase: NA
-
Autophagy in Systemic Lupus Erythematosus
NCT03583853 ·Status: UNKNOWN
-
Systemic Lupus Erythematosus and Accelerated Aging
NCT05698173 ·Status: RECRUITING ·Phase: NA
-
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
NCT02955615 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294 ·Status: RECRUITING
-
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-Based Detection Of Subclinical Arthritis Among Patients With Systemic Lupus
NCT05844917 ·Status: UNKNOWN ·Phase: NA